Skip to main content

Tag: risperidone

June 2014
Opinion / Viewpoint

How to evaluate new medications for autism

by  /  10 June 2014

There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.

April 2014

Risperidone use in children with autism carries heavy risks

by  /  28 April 2014

Risperidone, the first drug approved for children with autism and the most widely used, improves some children’s behavior but can have severe side effects, suggests an informal analysis of the drug’s use. 

December 2013

Many children with autism take multiple drugs

by  /  3 December 2013

It’s common for children with autism to take more than one medication to improve symptoms, despite the dearth of information about the drugs’ long-term safety, according to two new studies.

September 2013

World of drugs

by  /  20 September 2013

The most popular drugs prescribed for autism in some countries often have serious side effects or have not been vetted in robust clinical trials, finds a study published 5 September in Psychopharmacology.

1 Comment
June 2013

Medication nation

by  /  28 June 2013

U.K. doctors prescribe fewer medications for autism than doctors in the U.S., perhaps due to tighter drug laws and a more conservative medical culture, suggests a new study, published 17 May in Psychopharmacology.

1 Comment
March 2013

Clinical research: Risperidone boosts milk hormone

by  /  29 March 2013

Long-term treatment with risperidone — an antipsychotic approved to treat autism — may boost levels of prolactin, a hormone that stimulates milk production, according to a study published in December in the Journal of Child and Adolescent Psychiatry. Risperidone use may also affect sexual function and lead to enlarged breasts in males, the study found.


Alzheimer’s drugs hold promise for autism

by  /  11 March 2013

A growing number of studies suggest connections between Alzheimer’s disease, fragile X syndrome and autism, which could point the way to potential treatments.

December 2012

Treatments: In the waiting room

by  /  6 December 2012

After years of making do with drugs developed for other conditions, doctors and scientists are eagerly pursuing drugs that target the social symptoms of autism.

1 Comment
October 2012

Social molecule disrupted in autism mouse model

by  /  17 October 2012

Mice missing the autism-linked gene CNTNAP2 have broad defects in their oxytocin system, according to research presented Tuesday at the Society for Neuroscience annual meeting in New Orleans. Treatment with oxytocin alleviates social deficits in these mice.


Genetics: RNA improvisations altered in autism

by  /  9 October 2012

RNA editing, which creates multiple forms of a protein, is common among proteins involved in neuronal signaling, and may be abnormal in people with autism, according to a study published 7 August in Molecular Psychiatry.